Advertisement

Topics

NRG Oncology awarded NCI funding for next 6 years, receives 'exceptional' score

20:00 EDT 16 Apr 2019 | AAAS

(NRG Oncology) NRG Oncology, a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group conducting practice-changing clinical and translational research, has been awarded funding of over $95 million by the NCI for the next six years to continue its work as a lead protocol organization (LPO) program.

Original Article: NRG Oncology awarded NCI funding for next 6 years, receives 'exceptional' score

NEXT ARTICLE

More From BioPortfolio on "NRG Oncology awarded NCI funding for next 6 years, receives 'exceptional' score"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...